Completed
A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
NCT00512902
- Conditions
- Alveolitis, Connective Tissue Diseases, Scleroderma, Systemic, +3 more
- Locations
-
- UCLA David Geffen School of Medicine, Division of Rheumatology Los Angeles, California, United States